Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Eneda Toska
Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
122
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Number of pages: 51
Posted: 17 Dec 2019
Emiliano Cocco
,
Ji Eun Lee
,
Srinivasaraghavan Kannan
,
Alison M. Schram
,
Helen Won
,
Sophie Shifman
,
Amanda Kulick
,
Laura Baldino
, Eneda Toska,
Sabrina Arena
,
Benedetta Mussolin
,
Ram Kannan
,
Neil Vasan
,
Alexander N. Gorelick
,
Michael F. Berger
,
Yi Liao
,
Uwe Rix
,
Alberto Bardelli
,
Jacklyn Hechtman
,
Elisa de Stanchina
,
David M. Hyman
,
Chandra Verma
,
Andrea Ventura
,
Alexander Drilon
and
Maurizio Scaltriti
Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Cancer Biology and Genetics Program, Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center - Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, University of Torino - Department of Oncology, FPO-IRCCS - Candiolo Cancer Institute, Memorial Sloan Kettering Cancer Center - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute - Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute - Department of Drug Discovery, University of Torino - Department of Oncology, Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center - Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center - Department of Medicine, Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Memorial Sloan Kettering Cancer Center - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center - Department of Medicine and Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program
Downloads
122
(588,531)
View PDF
Download
Abstract:
drug resistance, tyrosine kinase inhibitors, cancer, signaling
Feedback